{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01275",
      "entity_text" : "GLP-1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00422",
      "entity_text" : "DPP-4 inhibitors",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In type 2 diabetes DPP-4 inhibitors reduce the breakdown of GLP-1 and improve metabolic control by increasing insulin secretion, improving beta-cell function, and decreasing glucagon secretion.",
  "reading_complete" : "2020-07-28T15:37:50Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T15:36:31Z",
  "trigger" : "reduce",
  "evidence" : [ "DPP-4 inhibitors reduce the breakdown of GLP-1" ],
  "pmc_id" : "3161271",
  "score" : 0
}